{
    "clinical_study": {
        "@rank": "82226", 
        "acronym": "ROM", 
        "arm_group": {
            "arm_group_label": "AL-SENSE 1-Step", 
            "arm_group_type": "Experimental", 
            "description": "a single AL-SENSE 1-Step to use up to 12 hours or until they notice any wetness."
        }, 
        "brief_summary": {
            "textblock": "Clinical diagnosis of amniotic fluid leak will be determined, according the hospital\n      standard procedure, using pooling test and/or sterile speculum examination and /or pH test,\n      and AmniSure, N-Dia, Inc. (immunoassay for diagnosis of ruptured fetal membranes (ROM)).\n      Amniotic fluid leak test, using the AL- SENSE 1-Step device, will be considered positive in\n      case of presence of a blue or green or grey stain on a yellow background of the AL-SENSE\n      1-Step, as observed by the patient and the clinician (positive/negative)."
        }, 
        "brief_title": "AL-SENSE 1-Step - Determination of Product Specificity", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "PREMATURE RUPTURE OF MEMBRANES", 
        "condition_browse": {
            "mesh_term": [
                "Fetal Membranes, Premature Rupture", 
                "Rupture"
            ]
        }, 
        "detailed_description": {
            "textblock": "Pregnant women arriving at the hospital and reporting unidentified wetness (undetermined\n      whether they sense amniotic fluid leakage or urinary incontinence) will receive a single\n      AL-SENSE 1-Step to use up to 12 hours or until they notice any wetness. The clinician will\n      explain the proper use and handling of the AL-SENSE 1-Step and how to read the result.\n\n      In each case, the subject and the clinician/midwife (non bias to the hospital standard\n      procedure results) will be required to read and record any occurrence of color change of the\n      AL-SENSE 1-Step immediately after removing the test to mark if it changes color to blue or\n      to green or to grey on the designated form.\n\n      The non bias physician, who is not aware to the AL-SENSE 1-Step result (other than the\n      clinician/midwife who records the AL-SENSE 1-Step results) will perform a diagnosis tests\n      for amniotic fluid leak detection, according to the hospital standard procedure.\n\n      The investigator will compare the AL-SENSE 1-Step results reading of the patient to the\n      clinical diagnosis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. AgE 18 years OR GREATER.\n\n          2. Subject who will sign the informed consent form.\n\n          3. Subject who arrive at the obstetric department reporting a feeling of vaginal wetness\n             feeling (undetermined whether she sense amniotic fluid leakage or urinary\n             incontinence).\n\n        Exclusion Criteria:\n\n          1. Subjects that have had sexual relations within the last 12 hours.\n\n          2. Subject is unable or unwilling to cooperate with study procedures.\n\n          3. Subject is currently participating in another clinical study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01804348", 
            "org_study_id": "F-7-32.2-1", 
            "secondary_id": "0096-12-NHR"
        }, 
        "intervention": {
            "arm_group_label": "AL-SENSE 1-Step", 
            "description": "a single AL-SENSE 1-Step to use up to 12 hours or until they notice any wetness.", 
            "intervention_name": "AL-SENSE 1-Step", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "PROM", 
        "lastchanged_date": "March 4, 2013", 
        "location": {
            "contact": {
                "email": "Jacob.Bornstein@naharia.health.gov.il", 
                "last_name": "Jacob Bornstein, MD", 
                "phone": "+972-4-9107720"
            }, 
            "facility": {
                "address": {
                    "city": "Nahariya", 
                    "country": "Israel"
                }, 
                "name": "Western Galilee Hospital"
            }, 
            "investigator": {
                "last_name": "Jacob Bornstein, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "AL-SENSE 1-Step - Determination of Product Specificity", 
        "overall_official": {
            "affiliation": "Western Galilee Hospital  Nahariya, Israel", 
            "last_name": "Jacob Bornstain, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: the israeli national institue for health policy research and health services research.", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "amniotic fluid leaks", 
            "safety_issue": "Yes", 
            "time_frame": "up to 12 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01804348"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Common Sense", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Common Sense", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}